Galderma Wins FDA Approval for Vectical Ointment

Galderma Laboratories, L.P. announced that the U.S. Food and Drug Administration (FDA) has approved Vectical (calcitriol) Ointment 3mcg/g, a unique vitamin D3 product for the treatment of mild-to-moderate plaque psoriasis in adults.
The Earth Times